Business Wire

Binatone Acquires License Rights to Motorola Mobility’s Accessories to Scale Its Global Business

3.9.2015 16:00 | Business Wire

Del

Binatone Global, a leading provider of IoT connected consumer electronics and lifestyle products, has acquired exclusive license rights to design, develop and market certain Motorola accessory products.

“We are excited to announce this next step in our growing partnership with Motorola Mobility," said Dino Lalvani, Chairman of Binatone. “Accessories are an integral part of enhancing the consumer experience in the mobile world, and Motorola has developed innovative technologies in this space. We see interesting opportunities to bring our innovations in IoT connectivity to this class of devices through our Hubble Connected Platform.”

Binatone began its longstanding collaboration with Motorola Mobility in 2008, and is currently the official licensee for Motorola baby monitors, home and pet monitors. This new agreement will add a range of consumer mobile accessory products including mono and stereo Bluetooth headsets, wireless speakers and car connectivity products to its portfolio of licensed products.

“We are very pleased to expand our relationship with Binatone and are looking forward to cooperating with them to expand the reach of these innovative products worldwide,” said Kouji Kodera, Senior Vice President of Product at Motorola.

As part of this exclusive licensing business model, Binatone will design, manufacture and deliver this class of products to markets worldwide under the Motorola brand. Motorola and Binatone teams are working together to make this a seamless transition for both customers and suppliers. Binatone will take over as the responsible party for supplying existing and new Motorola branded accessories in these categories worldwide from October 2015.

“Last year we put together a new strategic plan to transform and scale our business to become the global leader in IoT connected ‘emotional home,’” said Kanwar Chadha, Executive Chairman of Binatone. “This transaction is an integral part of our overall strategy to strengthen the company through both organic growth and acquisitions and bring a rich portfolio of Hubble Connected devices to enhance consumer experience.”

Hubble is Binatone’s IoT platform, with global coverage, that connects a broad range of devices to cloud using multiple connectivity technologies and provides end to end solutions and services to consumers.

For additional information or interview requests, please contact Kendal Hurley at Kendal@ballantinespr.com or 310-454-3080.

About Binatone:
Binatone is a leading provider of IoT connected innovative consumer electronics and lifestyle products for a broad range of applications with focus on “Emotional Home” including baby nursery, pet world and family connectivity at home and on the move. Its products are sold under world-leading brands such as Motorola, AEG, Binatone and iDECT. For over 56 years, Binatone maintains its position as a key player in the consumer electronics industry by offering innovative products and solutions.

For more information, visit www.binatoneglobal.com.

About Hubble:
Hubble Connected Limited (‘Hubble’) is a global Internet of Things (IoT) Solutions and Platform-as-a-Service (PaaS) provider. The Hubble platform enables operators and service providers to enhance their offerings and leading global original equipment manufacturers (OEM) to deliver fully integrated connected propositions with rich applications that include live video streaming, cloud recording and GPS tracking. Hubble has an industry leading ability to offer affordable full global cellular connectivity. As well as directly connecting a host of leading global brands such as Motorola, Binatone, AEG, VTech and Beurer, Hubble is a member of the AllSeen Alliance and Thread Group.

For more information, visit www.hubbleconnected.com.

Contact information

Ballantines PR
Kendal Hurley, 310-454-3080
Kendal@ballantinespr.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom